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Abstract
This study aimed to evaluate the efficacy of an 
emodepside 2.1 % (w/v)/praziquantel 8.6 % (w/v) 
topical solution (Profender® spot-on for cats) in the 
prevention of lactogenic Toxocara cati infections. 
A controlled test was performed with two groups 
of 8 cats with confirmed pregnancy. All cats were 
infected with daily doses of 2000 T. cati eggs for 
10 consecutive days starting 50 days post concep-
tion to produce an acute infection. Treatment was 
performed 60 days post conception. Queens in the 
treatment group received the emodepside/prazi-
quantel solution at the minimum therapeutic dose 
(3 mg/kg emodepside and 12 mg/kg praziquantel), 
while the control group was treated with a placebo 
spot-on. Efficacy was evaluated 56 days post par-
tum by necropsy of one randomly selected kitten 
of each litter and comparison of the worm burdens 
between the study groups. Additionally the nec-
ropsy results were supported by quantification of 
worms expelled with the faeces after deworming 
of the remaining kittens and all queens. The treat-
ment in late pregnancy resulted in an efficacy of 
98.7 % (p < 0.0001). All necropsied control kittens 
were infected (geometric mean 30.6). Seven of 8 kit-
tens from treated mothers were free of T. cati (geo-
metric mean 0.4). Worm counts after deworming 
reflected the results obtained at necropsy. No side 
effects of the treatment were observed. It is con-
cluded that treatment with an emodepside/prazi-
quantel spot-on solution during late pregnancy 
effectively prevents lactogenic transmission of 
T. cati to the offspring. The study design facilitated 
the generation of reliable data, while at the same 




Vertical transmission, i.e. transmission of devel-
opmental stages from the infected mother to the 
offspring either prenatally or by the transmam-
mary pathway, is a major component in the life 
cycles of several species of parasitic helminths 
(Miller 1981; Shoop 1991). It occurs predominantly 
in nematodes, but some trematode species such as 
Alaria spp. (Shoop and Corkum 1983, 1984; Foster 
et al. 2009) and cestodes, e.g. Mesocestoides corti 
(Conn and Etges 1983), have also been reported to 
be vertically transmitted.
The biological significance of these transmission 
routes has been demonstrated for many species of 
the genus Strongyloides (Lyons et al. 1973; Stew-
art et al. 1976; Wilson et al. 1978; Nwaorgu and 
Onyali 1990), for Toxocara spp. in dogs (Burke and 
Roberson 1985a,b), cats (Swerczek et al. 1971) and 
bovines (Roberts et al. 1990) and for the hookworm 
species Ancylostoma caninum (Burke and Roberson 
1985a,b) and Uncinaria lucasi (Olsen and Lyons 
1965). The lactogenic route is more common than the 
transuterine pathway and the pattern of transmis-
sion varies between species (Shoop 1991). In several 
species the transmission of hypobiotic larvae that 
are reactivated during late pregnancy is a pathway 
of great biological importance. These larvae invade 
the foetuses directly or accumulate in the mammary 
glands to be transmitted via the milk after parturi-
tion. While both ways of vertical transmission occur 
in bitches chronically infected with Toxocara canis, 
Toxocara cati has only been shown to be lactogeni-
cally transmitted after acute infection during late 
pregnancy (Coati et al. 2004) (Fig. 1).
Toxocara cati is the most common gastrointesti-
nal helminth of cats worldwide. In stray cats and 
fostered cats prevalences of up to 44 % are found 
(Becker et al. 2012; summarised by Wolken et al. 
2009). But also privately owned cats are regularly 
infected. Especially young kittens are at high risk 
of infection, which can be explained by the verti-
cal transmission of this parasite. In a study by 
Barutzki and Schaper (2013) Infection rates of up to 
11.4 % were found in kittens younger than 3 month. 
Various attempts at anthelmintic treatment of the 
dam to protect the offspring from vertical infections 
have been made in the past. These studies mainly 
focused on dogs for the control of neonatal infec-
tions with T. canis or A. caninum (see Krämer et al. 
2006 and 2009 for an overview of treatment proto-
cols) and on Strongyloides spp. in pigs (Barth et al. 
1996; Drag et al. 1998) and horses (Ludwig et al. 
1983). Concerning T. cati, a study by Wolken et al. 
(2009) used faecal egg counts (FEC) to evaluate 
the efficacy of an emodepside/praziquantel spot-on 
treatment in the prevention of lactogenic infections. 
Egg shedding was completely prevented in the off-
spring (n=10) of 4 queens that had received a single 
treatment during late pregnancy. The aim of the 
study presented here was to verify the hypothesis 
that a single treatment with emodepside/prazi-
quantel spot-on treatment will prevent lactogenic 
transmission of T. cati in a controlled test using 
necropsy worm counts as an efficacy criterion as 
recommended by anthelmintic guidelines.
Materials and methods
The study was performed as a monocentric, pla-
cebo-controlled, randomised and blinded efficacy 
study. As no detailed guideline on vertical trans-
mission studies exists, the study was performed in 
accordance with VICH guideline 9 “Good Clinical 
Practice” (June 2000). Furthermore the recom-
mendations given in VICH Guideline 7 “Efficacy of 
anthelmintics: general requirements” (November 
2000), VICH Guideline 20 “Efficacy of anthelmin-
tics: Specific Recommendations for Felines” (June 
2001) and the WAAVP guidelines for evaluating the 
efficacy of anthelmintics for dogs and cats (Jacobs 
et al. 1994) were followed whenever possible. The 
general study design was based on experience pub-
lished in the scientific literature (Coati et al. 2004; 




Sixteen female domestic short-hair cats, aged 
between 1.5 and 6.5 years and originating from the 
cat colony of the Institute for Parasitology, Uni-
versity of Veterinary Medicine Hannover, were 
included in the study. The animal experiment was 
approved by the ethics commission of the State 
Office for Consumer Protection and Food Safety of 
the German federal state Lower Saxony. Due to 
the fact that it was not possible to have 16 preg-
nant queens at a time, the study was conducted 
during various breeding seasons between March 
2012 and November 2013. Mating, parturition and 
rearing proceeded under natural conditions with 
the exception of one queen where a caesarean sec-
tion was necessary. Whenever a cat showed signs 
of oestrus, it was brought together with the tomcat. 
In order to have a precise mating date the couple 
stayed together for no longer than one day. Preg-
nancy was confirmed by ultrasonic examinations 
approximately 3 weeks after mating. The num-
ber of foetuses was determined and later used for 
Fig. 1: Life cycle of Toxocara cati including location and ﬁ rst time point of appearance of the developing larval stages 
(*occurrence of larvae in the respective organ according to Sprent 1956)
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randomization (see section “allocation and treat-
ment” below). Only queens with more than one live 
fetus at the ultrasound examination were included 
in the study. Queens and their litters were indi-
vidually housed in tiled indoor pens with a floor 
space of 2.1 to 7.7 m2 and a height of approximately 
2.3 m. Shortly before expected parturition a whelp-
ing area was provided. The cats received amuse-
ment toys for environmental enrichment as well as 
daily grooming and playing time with the animal 
attendants. The pens were cleaned with 60 – 80 °C hot 
water and disinfected with cresole (Neopredi san®, 
Menno Chemie-Vertrieb GmbH) on a regular basis. 
The cats had unlimited access to water and were 
fed standard diets (Pediatric Queen®, Pediatric 
Weaning®, Royal Canin). For collection of individual 
faeces at study end the queens and kittens were 
housed singly in plastic coated wire cages equipped 
with a raised resting area, litter tray and toys for 
enrichment. Cats were handled with due regard to 
their well-being.
Health observations
General health observations were conducted daily. 
Physical examinations of the queens were performed 
twice between mating and the first experimental 
infection and on the day of treatment. Only healthy 
cats were included in the study. All queens and 
kittens underwent a physical examination within 
48 hours after parturition and at study end (56 days 
after parturition). Clinical assessments were per-
formed prior to treatment and at 3 and 24 hours post 
treatment. Body weights in queens were determined 
on study day 0 for dosing, in kittens within 48 hours 
after birth and in all cats at study end.
Experimental infections
Cats were infected with embryonated T. cati eggs 
recovered from the faeces of an experimentally 
infected cat. The strain was maintained at the 
Institute for Parasitology, University of Veteri-
nary Medicine Hannover and originated from a 
field isolate identified in Germany in 2010. The 
eggs were microscopically checked for viability of 
larvae, suspended in tap water and applied orally 
with a syringe. Starting 50 days after conception 
each queen was infected daily with approximate-
ly 2,000 infective T. cati eggs for 10 consecutive 
days (study day -10 to -1) to produce an acute 
infection. 
Allocation and treatment
In order to have an equal distribution of kittens in 
the treatment groups, the queens were allocated 
according to the results of the ultrasonic examina-
tion. Based on the expected litter size the queens 
were assigned to one of 2 random draws, one for an 
expected litter size of 2 to 4 kittens and one for a lit-
ter size equal to or greater than 5. The queens were 
allocated in the order they had their ultrasound 
examination. Treatment was performed on study 
day 0 (one day after the last experimental infec-
tion). Queens treated with the investigational vet-
erinary product (IVP) (Profender® spot-on for cats) 
were dosed with 0.14 mL of the spot-on formulation 
per kilogram (kg) body weight, which corresponded 
to the recommended minimum therapeutic dose of 
3 mg/kg emodepside and 12 mg/kg praziquantel. 
Cats assigned to the control group were treated 
with a placebo spot-on formulation, using the same 
amount of 0.14 mL per kg body weight to mimic 
the appearance of the IVP. Treatments were per-
formed according to the label instructions of the 
manufacturer. 
Faecal examinations
Three faecal egg counts (FEC) were performed 
during the week prior to the first experimental 
infection to demonstrate the parasitological status 
of the cats. For study inclusion these counts had 
to be negative for nematode eggs. To monitor the 
onset of patency, FECs were performed 3 times per 
week starting 13 days post partum (p.p.) in queens 
and 21 days p.p. in kittens. Due to the mother’s 
intensive grooming activities it was difficult to 
obtain individual faecal samples from the kittens. 
Therefore, efforts were made to receive at least a 
faecal smear directly from the rectum (by the use 
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of a cotton bud) to demonstrate the parasitologi-
cal status of the individual kitten. A few pooled 
faecal samples from the whole litter were found 
by chance and examined additionally. A final indi-
vidual FEC was performed at study end to dem-
onstrate the success of the final deworming. FECs 
were performed using a modified McMaster tech-
nique (Wetzel 1951).
Necropsy
56 days p.p. one kitten from each litter was ran-
domly selected and euthanised for necropsy. An 
exception from random selection was made when, 
due to the premature death of the siblings, only 
one kitten was left on the day of necropsy and in 
one case where a kitten in the control group was 
affected by a congenital deformation of the tarsal 
joint. For ethical reasons this kitten was selected 
for necropsy.
At necropsy the digestive tract from the beginning 
of the stomach to the rectum was removed and 
the intestinal content and the results of several 
mucosal strippings were washed over sieves with 
mesh size of 50 µm (stomach and small intestine) 
or 100 µm (large intestine). All contents were ana-
lysed under a stereo microscope and the recovered 
parasites were counted and identified for species 
and developmental stage. 
Deworming and collection  
of excreted worms
On day 56 p.p. all queens and those kittens that 
were not selected for necropsy were dewormed with 
pyrantel embonate plus praziquantel (Drontal® 
tablets for cats, Bayer) at the dose recommended 
by the manufacturer. All faeces were collected for 
at least 3 days and examined macroscopically for 
excreted worms. 
Efficacy determination and  
statistical analysis
The adequacy of infection was determined accord-
ing to VICH guidelines 7 and 20. These require a 
minimum of 6 animals in the control group with at 
least 5 worms each. Additionally the lower limit 
of the 95 % confidence interval was required to be 
greater than 10 % of the central tendency (geomet-
ric mean as all counts were > 0). 
Percentage efficacy of the treatment was calculat-
ed according to VICH guideline 7 and the WAAVP 
guideline for evaluating the efficacy of anthelmin-
tics for dogs and cats (Jacobs et al. 1994) as follows:
% Effectiveness (reduction) = (N1 – N2)/N1 x 100
N1:  geometric mean (GM) of T. cati counts in kittens 
from placebo treated queens
N2:  geometric mean (GM) of T. cati counts in kittens 
from Profender® treated queens
For these calculations the sum of all T. cati stages 
that were found at necropsy (larvae, premature 
and adult stages) was used. Due to the presence 
of worm count values of “0”, all counts were modi-
fied by adding 1 prior to log transformation and 
subtracting 1 from the antilog value. The non-
parametric Wilcoxon rank sum test (two tailed, 
α = 0.05) was used to test for a treatment group 
(emodepside/praziquantel vs. placebo) effect. 
Additionally the medical relevance of the differ-
ence between the groups was quantified using the 
Mann-Whitney superiority measure (MW) and its 
two-sided 95 % confidence interval as the corre-
sponding effect size. The analyses were performed 
using the software Testimate Version 6.5 (IDV 
Gauting). 
Results
The duration of pregnancy was within physiologi-
cal limits (Linde-Forsberg and Eneroth 1998) and 
varied between 63 and 68 days in the IVP-treated 
group and between 64 and 69 days in the control 
group. Due to these variations, the implemented 
study design resulted in a treatment time point 
between 3 and 9 days pre partum. A total of 54 kit-
tens (29 in the control group, 25 in the IVP treated 
group) were borne during the study. One litter had 
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to be delivered by caesarean section after the still 
birth of one kitten and subsequent absence of con-
tractions. Rearing of this litter proceeded under 
natural conditions. Six kittens in the control group 
and 2 in the IVP-treated group were born dead or 
died during the study. It became apparent that 
infections with the Feline Leukemia Virus (FeLV) 
were present in the study population. Two kittens 
in a control litter showed deformation of the tar-
sal joints at birth. While one kitten recovered and 
showed normal development during the study, 
the other was still affected at study end. All other 
kittens and the queens stayed clinically healthy 
throughout the study. No negative side effects of 
the treatment were detected. 
The acute infection during late pregnancy pro-
duced patent infections in 7 of 8 queens in the 
control group. Onset of patency was between 
43 and 69 days after the first experimental infec-
tion. Requirements for an adequate infection in 
the control group were fulfilled. All 8 necropsied 
kittens harboured T. cati (range: 7 – 72, GM = 30.6) 
(Tab. 1). Seven kittens from the IVP-treated queens 
were negative at necropsy. One kitten harboured 
a total of 12 T. cati in the intestine (GM = 0.4). 
The treatment resulted in an efficacy of 98.7 %. 
The Profender®-treated group was highly statis-
tically significantly superior to the control group 
(p <  0.0001, MW-statistic = 0.9766).
Seven queens in the control group excreted worms 
after deworming (range 1 – 202). The queen that 
was constantly negative at the FEC examinations 
(litter ID 15) also did not excrete worms. In con-
trast, the necropsied kitten from this queen, which 
was the only kitten that was left in this litter at nec-
ropsy, showed a high worm burden (55), confirming 
successful vertical transmission in this litter too. In 
13 of 15 dewormed control kittens excreted worms 
could be found in the faeces (range 1 – 39). In one 
litter (litter ID 9) 2 control kittens showed no worm 
excretion. However, a third kitten of the same litter 
excreted 13 T. cati stages. Two of 15 kittens from 
Profender-treated queens each excreted 3 worms 
after deworming. These 2 kittens belonged to the 
same litter as the kitten that was positive at nec-
ropsy (litter ID 6) (Tab. 1).
Discussion
The aim of this study was to verify preliminary data 
from a study by Wolken et al. (2009) on the efficacy 
of an emodepside/praziquantel spot-on formulation 
(Profender® for cats) in the prevention of vertical 
transmission of T. cati in cats. As suggested by the 
anthelmintic guidelines, a controlled test was used. 
No detailed recommendations existed regarding the 
design for a vertical transmission study, therefore 
the general requirements of the anthelmintic guide-
lines were implemented together with the stand-
ards of GCP and current scientific knowledge.
To date it has been shown that lactogenic trans-
mission of T. cati larvae occurs only after acute 
infection of the queen during late pregnancy and 
not during chronic infections (Coati et al. 2004). 
To mimic this situation, the infection protocol 
used by Coati et al. (2004) and Wolken et al. (2009) 
was successfully adopted in this study. Vertical 
infection was proven in 21 of 23 kittens in the 
control group. Two kittens that did not excrete 
T. cati stages after deworming belonged to a litter 
with 4 kittens. The necropsied kitten, the fourth 
kitten and the mother were infected, confirming 
successful vertical transmission in all 8 control 
litters. Due to the scarce literature dealing with 
vertical transmission of T. cati, it is almost impos-
sible to assess the biological variability that can be 
expected in terms of transmission rates. The only 
2 studies reporting detailed data showed trans-
mission rates of 100 % in kittens necropsied 8 to 
22 days p.p. (Coati et al. 2004) or 5 to 20 days p.p. 
(Swerczek et al. 1971). Altogether data from these 
two publications represent the results of 8 litters 
with a total of 21 kittens that were allowed to 
nurse long enough for transmission to take place. 
Three kittens examined 1 or 3 days p.p. by Coati 
et al. (2004) were not infected.
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One queen in the control group stayed coproscopi-
cally negative throughout the study. Her kitten, 
however, was positive at necropsy, providing proof 
of a technically correct experimental infection of 
the mother. This queen was the same one that 
needed a caesarean section. Whether the cause of 
the absent colonization of the queen’s intestine is 
just biological variance or the result of a negative 
influence of the anaesthesia can only be speculated. 
Coati et al. (2004) performed a caesarean section 
on 4 chronically T. cati-infected queens with posi-
tive FECs to evaluate the possibility of prenatal 
infections. All queens stayed coproscopically posi-
tive throughout the observation period of several 
weeks after surgery. Therefore the anaesthesia 
had no negative effect in this case. It has to be con-
sidered, however, that different anaesthetics may 
have been used and that the worms in the study 
by Coati et al. (2004) were adult at the time of 
caesarean section. In the study presented here the 
coproscopically negative queen was infected 13 to 
4 days prior to surgery. According to Sprent (1956), 
larvae first appear in the lungs on day 3 post infec-
tion, and reach the intestine by day 19 post infec-
tion. Starting day 10 p.i. larvae can be found in the 
muscle tissue. It thus seems possible that tissue 
migrating larvae from the first days of infection 
had already reached the mammary glands on the 
day of caesarean section, and were not affected by 
the anaesthetic while larvae on the route of trache-
al migration were exposed to high concentrations. 
Nevertheless, an influence of general anaesthesia 
on the worm burden has to our knowledge not been 
reported before in veterinary medicine. 
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3 0 0 0
4 0 0 0
5 0 0 0
6 12 3/0/0/0/3 0
7 0 0/0/0 0








10 50 17/26 202
11 72 – 113
12 7 6/4 37
13 12 1/24/13 1
14 34 2/39/14 167
15 55 – 0
16 43 1/25 5
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The treatment was well tolerated by the queens 
and no negative side effects were seen in the kit-
tens. Still births and premature deaths in both 
study groups were most likely due to an infection 
with the Feline Leukemia Virus (FeLV), which 
is associated with abortions, still birth and weak 
kittens (“Fading Kitten Syndrom”) (Hartmann 
2012).
Necropsy worm counts in kittens from Profender®‐
treated queens were reduced by 98.7 % compared 
to kittens from queens that received the placebo 
solution. Seven of 8 kittens in the treated group 
were negative at necropsy. For ethical reasons only 
one kitten per litter was euthanised and examined 
for stages of T. cati. To take account of biological 
variations, and therefore to minimize the risk 
of selecting a negative kitten for necropsy while 
other kittens of the litter were positive, the results 
obtained by necropsy were supported by dewor-
ming the remaining kittens and all queens and 
collecting the excreted worms. The results obtained 
by deworming reflected those at necropsy. One kit-
ten from a treated queen was positive at necropsy 
and belonged to a litter with 6 kittens. Two further 
kittens from this litter were positive at dewor ming, 
the other 3 and the queen were negative. All other 
queens and kittens in the treated group were also 
negative. When expelled worms after dewor ming 
are used to determine worm burdens like it is 
done in a critical test, no drugs may be used that 
destroy the parasite’s body (VICH GL7). The use 
of pyrantel and the fact that ascarids have a thick 
hypodermis and cuticula, and are thus not easily 
digested, allowed reliable data to be generated by 
this method.
None of the kittens developed a patent T. cati infec-
tion. This can be explained by the fact that mainly 
pre-adult stages and only single adults were found 
in the kittens. Information in the literature on the 
prepatent period after lactogenic transmission of 
T. cati is scarce. Kittens of one litter in the study 
by Coati et al. (2004) became patent on days 44, 
53 and 55 after birth. In the study by Wolken 
et al. (2009) one litter in the control group became 
coproscopically positive 36 days after birth and 
the other on day 50 after birth. A different T. cati 
strain was used in the present study that might 
have exhibited different biological properties. Bio-
logical variations have to be considered in every 
study with experimental infections. The results 
of this study demonstrate that the study design 
was able to cope with these variations, while at 
the same time a minimum number of animals were 
sacrificed. But the fact, that not all kittens in the 
control group were infected also shows that sup-
portive data are important to exclude false nega-
tive results in a vertical transmission study design 
that avoids euthanasia of the whole offspring.
It can be concluded, that a single treatment of 
queens with an emodepside/praziquantel topical 
solution (Profender® spot-on) in late pregnancy 
is safe and effectively prevents the offspring from 
becoming infected with T. cati via nursing.
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